IMPAACT 2023: A Phase I Study of the Safety and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-107/01/2022 - 06/30/2025 (Subcontract PI)
PI:
Diana F. Clarke, PharmDJohns Hopkins University ViiV Healthcare
IMPAACT Protocol Leadership: 2032 Protocol Vice Chair Remdesevir07/01/2023 - 11/30/2023 (Subcontract PI)
PI:
Diana F. Clarke, PharmDJohns Hopkins University NIH NIAID5UM1AI068632-17
IMPAACT 2032: Pharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the United States12/01/2021 - 06/30/2023 (Subcontract PI)
PI:
Diana F. Clarke, PharmDJohns Hopkins University Gilead Sciences
LOC-IMPAACT Leadership Group: Pharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant Women in the US06/01/2020 - 11/30/2022 (Subcontract PI)
PI:
Diana F. Clarke, PharmDJohns Hopkins University NIH NIAID3UM1AI068632-14S2
LOC-IMPAACT Leadership Group - IMPAACT 2023/P1097 Protocol Chair12/01/2018 - 06/30/2022 (Subcontract PI)
PI:
Diana F. Clarke, PharmDJohns Hopkins University NIH NIAID
LOC-IMPAACT Leadership Group - Merck 1097P 01/01/2020 - 12/31/2020 (Subcontract PI)
PI:
Diana F. Clarke, PharmDJohns Hopkins University Merck
P1097A – TO# LDR 04 MOD 03 – Raltegravir Pharmacokinetics and Safety in Neon…..01/01/2014 - 11/30/2020 (PI)
Johns Hopkins University Merck
P1097A - TO# LDR 04 MOD 02 - Raltegravir Pharmacokinetics and Safety in Neonates01/01/2014 - 10/01/2020 (PI)
Johns Hopkins University NIH-NIAID
LOC-IMPAACT Leadership Group - JHU P1097 and P111001/01/2014 - 11/30/2015 (PI)
Johns Hopkins University NIH-NIAID5 UM1 AI068632-09
IMPAACT Leadership Award: Chair, Protocol P109706/01/2012 - 12/31/2013 (PI)
Johns Hopkins University NIH-NIAID
Showing 10 of 14 results.
Show All Results
IMPAACT Leadership: Vice Chair Pharmacy Resource Committee
06/01/2012 - 12/31/2013 (PI)
Johns Hopkins University NIH-NIAID
IMPAACT Leadership: International Maternal Pediatric Adolescent AIDS Clinical Trials Group
06/01/2011 - 05/31/2012 (PI)
Social & Scientific Systems Inc. NIH-NIAID
IMPAACT Leadership - P1097 Protocol Chair
06/01/2011 - 05/31/2012 (PI)
Social & Scientific Systems Inc. NIH-NIAID
IMPAACT P1097
06/01/2010 - 05/31/2011 (PI)
Social & Scientific Systems Inc. NIH-NIAID